Objective: To study clinical therapeutic effect of Jianpi Xiaoji Oral Liquid on life quality in patients of late liver cancer. Methods: 62 cases were randomly divided into a treatment group（n=32） and a control group（n=30）. The two groups were treated by same western medicine therapy

i. e

liver-protecting and expectant treatment

with Jianpi Xiaoji Oral Liquid added to the treatment group. Results: The total short-term relieving rate was 62.5% in the treatment group and 40% in the control group（P<0.05）. The total improving rate for clinical symptoms was 75% and 53.30%

and the increasing and stabilizing rate was 68.8% and 43.3%

the survival rate was 65.6% and 37.5%

aud 40% and 23.3% for 6 months and 1 year in the two groups. respectively

with significant differences（P<0.05）. Conclusion: Jianpi Xiaoji Oral Liquid can improve clinical symptoms in the patient of late liver cancer

increasing life quality

prolonging survival time

stabilizing tumor body

effectively controlling condition of illness

which reflect unique advantages of integrated treatment of traditional Chinese and western medicine in treatment of late liver cancer.